InterConnect 3D Printed Ti Lumbar Interbody System
Commercial- Indications
- Spinal fusion
Company intelligence / Profile preview
ZSFab has received FDA 510(k) clearance for its first cervical fusion cage in January 2021 and its first lumbar interbody system in October 2022. The company’s InterConnect™ Lumbar Interbody System and Cervical Interbody System have been successfully used clinically in the US, with prior clinical use of the cervical system also reported in China. These devices feature advanced porous titanium lattice structures designed to enhance osseointegration, reduce subsidence, improve load distribution, and promote faster bone healing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZSFab.